Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2020, Vol. 47 Issue (2): 277-286    DOI: 10.31083/j.ceog.2020.02.5299
Original Research Previous articles | Next articles
Human placental suppressors of cytokine signalling (SOCS) and inflammatory cytokines are dysregulated in assisted reproduction, advanced maternal age and pre-term birth
S. J. Knight1, A. D. Smith1, H. Kim2, 3, 4, A. C. Collier1, *()
1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada
2Centre for Blood Research, University of British Columbia, University of British Columbia, Vancouver, Canada
3Faculty of Dentistry, University of British Columbia, Vancouver, Canada
4Department of Biochemistry and Molecular Biology, University of British Columbia, University of British Columbia, Vancouver, Canada
Download:  PDF(9536KB)  ( 291 ) Full text   ( 9 )
Export:  BibTeX | EndNote (RIS)      

Summary of Investigation: Assisted reproduction technologies (ART) are now commonly used to conceive. ART is associated with higher incidence of negative birth outcomes which may be due to altered cytokine signaling. Materials and Methods: This pilot study evaluated the suppressors of cytokine signaling SOCS and levels of proinflammatory cytokines ART and non-ART placentas (n=14 each) matched for maternal and gestational age, delivery method, pregnancy weight gain, and body mass index. Comparisons of advanced maternal age (AMA), with or without pre-term birth (PTB) were included. SOCS1, 2, and 3 levels were evaluated with immunohistochemistry and IFN-γ, IL1-β, IL-6, IL-8, IL-10, and TNF-α with ELISA. Results: ART was associated with significantly lower SOCS3. Although SOCS1/IL-10 and SOCS2 and 3/IFN-γ significantly associated in normal conception, associations were lost in ART. In AMA, placental SOCS1 and 2 were associated with IFN-γ, and SOCS3 with IL-6, but under 35 these associations were lost. Term birth was associated with placental SOCS1 inhibition of IL-8 and SOCS2 induction of IL-10, but PTB was not. Conclusion: Cytokine signaling is dysregulated in human placentas by ART which might be a cause of negative reproductive outcomes in ART.

Key words:  Advanced maternal age      Advanced maternal age      In vitro fertilization      Infertility      Inflammation      Parturition      Pre-term birth     
Published:  15 April 2020     
Fund: RMATRIX - 3U54MD007584-03S1/National Institutes of Health;MC2-127872/Canadian Institutes of Health Research (CIHR) Clinician-Scientist Salary Award Faculties of Dentistry and Pharmaceutical Sciences, UBC
*Corresponding Author(s):  A. C. Collier     E-mail:

Cite this article: 

S. J. Knight, A. D. Smith, H. Kim, A. C. Collier. Human placental suppressors of cytokine signalling (SOCS) and inflammatory cytokines are dysregulated in assisted reproduction, advanced maternal age and pre-term birth. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 277-286.

URL:     OR

Table 1  — Demographics of the cohort.
Normal conception (n = 14) Assisted reproductive technology (n = 14) p value
Maternal age (years) 33.77 ± 2.02 34.85 ± 1.24 0.55
Gestational age (days) 248.7 ± 30.9 248.2 ± 26.0 0.95
Delivery method
Caesarian 64 % (n = 9) 64 % (n = 9) 1
Vaginal 36 % (n = 5) 36 % (n = 5)
Pregnancy weight gain (kg) 11.2 ± 8.7 9.4 ± 3.9 0.57
Asian 61 % 48 % 0.12
Caucasian 28 % 48 % 0.008
Native Hawaiian/Pacific Islander 10 % 4 % 1
Nested study
n = 3
n = 3
n = 5
n = 3
n = 3
n = 3
n = 5
n = 3
Maternal age (years) 38.0 ± 2.0 42.3 ± 4.0 26.5 ± 4.9 30.7 ± 2.1 40.6 ± 3.1 37.0 ± 2.7 31.8 ± 1.7 31.0 ± 1.0
Gestational age (weeks) 33.5 ± 1.1 38.9 ± 0.7 30.4 ± 5 39.4 ± 0.9 34.2 ± 1.7 38.1 ± 1.2 32.3 ± 4.7 38.3 ± 0.9
Figure 1.  — Representative immunohistochemistry micrographs for SOCS 1, 2, and 3. Left column is negative control, right column is the ART slide (positive). Black arrows indicate positive DAB staining (brown) localized to the syncytium. Endothelial staining is not apparent. Counterstaining of nuclei (blue) is with Gill’s Hematoxylin. Despite quenching, slight non-specific staining of erythrocytes is noticeable.

Figure 2.  — SOCS expression levels in human placenta. A-C: Normal conception vs. assisted reproduction (ART); D-F: Term vs. preterm birth (PTB) regardless of conception method. G-I Advanced maternal age (AMA ≥ 35 years) vs. normal maternal age (< 35 years), regardless of conception method. Bars are means ± SEM. N values for each bar are listed underneath.

Figure 3.  — Correlations between SOCS and cytokines in placentas from normally conceived and ART pregnancies. A and B: SOCS1 correlates strongly with IL-10 in normally conceived placentas (p = 0.002, r = 0.77) but not in ART (p = 0.52, r = 0.19). C and D: SOCS2 correlates well with IFN-γ in normally conceived placentas (p = 0.02, r = 0.60) but not in ART (p = 0.80, r = 0.08), and E and F: SOCS3 correlates strongly with IFN-γ in normally conceived placentas (p = 0.02, r = 0.48) but not in ART (p = 0.56, r = 0.17). Solid line is the correlation fit, dashed line is the 95% confidence interval.

Figure 4.  — Significant associations between SOCS and cytokines in placental tissue from AMA pregnancies ñ these associations did not occur placentas from mothers under 35. A and B: SOCS1 is positively correlated with TNF-α (p = 0.04, r = 0.60) in placentas from AMA mothers, but the correlation does not occur in normal maternal age (p = 0.38, r = 0.28). B: SOCS2 is strongly correlated with TNF-α (p = 0.003, r = 0.80) in AMA, but not in normal maternal age (p = 0.93, r = -0.03). C: SOCS3 is strongly correlated with IL6 (p = 0.009, r = 0.73), but this is not observed in placentas from normal maternal aged women (p = 0.89, r = -0.04). Solid line is correlation fit, dashed line is 95% confidence interval.

Figure 5.  — Significant associations between SOCS and cytokines in term placental tissue, that were lost in pre-term birth. A and B: SOCS2 is correlated with placental IL-10 at term (p = 0.03, r = 0.62), but not in pre-term placentas (p = 0.01, r = 0.95). C and D: SOCS3 is negatively correlated with IL-8 (p = 0.03, r = -0.59) at term, but not in pre-term placentas (p = 0.59, r = -0.17). Solid line is correlation fit, dashed line is 95% confidence interval.

[1] Sunderam S., Kissin D., Crawford S., Folger S., Boulet S., Warner L., et al.: “Assisted Reproductive Technology Surveillance - United States, 2015.” MMWR Surveil. Summ. 2018, 67, 1.
[2] Lu Y., Wang N., Jin F.: “Long-term follow-up of children conceived through assisted reproductive technology.” Zhejiang Uni. Sci. B., 2013, 14, 359.
[3] Benirschke K., Kaufmann P.: “Pathology of the Human Placenta” . 4th ed. New York: Springer-Verlag, 2000.
[4] Keelan J., Blumenstein M., Helliwell R., Sato T., Marvin K., MItchell M.: “Cytokines, prostaglandins and parturition—a review”. Placenta, 2003, 24, S33.
[5] Fitzgerald J., Toth B., Jeschke U., Schleussner E., Markert U.: “Knocking off the suppressors of cytokine signaling (SOCS): their roles in mammalian pregnancy”. J. Reprod. Immunol., 2009, 83, 117.
[6] Soncin F., Khater M., To C., Pizzo D., Farah O., Wakeland A., et al.: “Comparative analysis of mouse and human placentae across gestation reveals species-specific regulators of placental development.” Development, 2018, 145, pii: dev156273.
[7] Sato B., Sugawara A., Ward M., Collier A.: “Single blastomere removal from murine embryos is associated with activation of matrix metalloproteinases and Janus kinase/signal transducers and activators of transcription pathways of placental inflammation”. Mol. Hum. Reprod., 2014, 20, 1247.
[8] Zhang Y., Zhao W., Jiang Y., Zhang R., Wang J., Li C., et al.: “Ultrastructural study on human placentae from women subjected to assisted reproductive technology treatments”. Biol. Reprod., 2011, 85, 635.
[9] Raunig J., Yamauchi Y., Ward M., Collier A.: “Assisted reproduction technologies alter steroid delivery to the mouse fetus during pregnancy”. J. Steroid Biochem. Mol. Biol., 2011, 126, 26.
[10] Raunig J., Yamauchi Y., Ward M., Collier A.: "Placental inflammation and oxidative stress in the mouse model of assisted reproduction". Placenta, 2011, 32, 852.
[11] Sugawara A., Sato B., Bal E., Collier A., Ward M.S.: “Blastomere removal from cleavage-stage mouse embryos alters steroid metabolism during pregnancy”. Biol. Reprod., 2012, 87, 1.
[12] Collier A., Miyagi S., Yamauchi Y., Ward M.A.: “Assisted reproduction technologies impair placental steroid metabolism.” J. Steroid Biochem. Mol. Biol., 2009, 116, 21.
[13] Grace K., Sinclair K.: “Assisted reproductive technology, epigenetics, and long-term health: a developmental time bomb still ticking”. Semin. Reprod. Med., 2009, 27, 409.
[14] Liebaers I., Desmyttere S., Verpoest W., De Rycke M., Staessen C., Sermon K., et al.: “Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis”. Hum. Reprod., 2010, 25, 275.
[15] Nicholas B.: “Community and justice: the challenges of bicultural partnership to policy on assisted reproductive technology”. Bioethics, 1996, 10, 212.
[16] Smith P., Krohn R., Hermanson G., Mallia A., Gartner F., Provenzano M., et al.: “Measurement of protein using bicinchoninic acid”. Anal. Biochem., 1985, 150, 76.
[17] Abanda N., Riches Z., Collier A.C.: “Lobular Distribution and Variability in Hepatic ATP Binding Cassette Protein B1(ABCB1 P-gp): Ontogenetic Differences and Potential for Toxicity”. Pharmaceutics, 2017, 9, pii:E8.
[18] Essakow J., Lauterpacht A., Lilos P., Kauli R., Laron Z.: “Genetic Mutations, Birth Lengths, Weights and Head Circumferences of Children with IGF-I Receptor Defects. Comparison with other Congenital Defects in the GH/IGF-I axis”. Ped. Endocrinol. Rev., 2016, 14, 19.
[19] Lubinsky M. “An epigenetic association of malformations, adverse reproductive outcomes, and fetal origins hypojournal related effects”. J Assist Reprod Genet. 2018, 35, 953-64.
[20] Lamminpää R., Vehviläinen-Julkunen K., Gissler M., Heinonen S.: “Preeclampsia complicated by advanced maternal age: a registrybased study on primiparous women in Finland 1997-2008”. BMC Pregnancy and Childbirth, 2012, 12, 47.
[21] Ashrafi M., Sheikhan F., Arabipoor A., Hosseini R., Nourbakhsh F., Zolfaghari Z.: “Gestational diabetes mellitus risk factors in women with polycystic ovary syndrome (PCOS)”. Eur. J. Obstet. Gynecol., 2014, 181, 195.
[22] Rawlings J., Rosler K., Harrison D.: “The JAK/STAT signaling pathway”. J. Cell. Sci., 2004, 117, 1281.
[23] Ding Y., Chen D., Tarcsafalvi A., Su R., Qin L., Bromberg JS.: “Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses”. J. Immunol.,. 2003, 170, 1383.
[24] Yu Y., Wan P., Cao Y., Zhang W., Chen J., Tan L., et al.: “Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action”. Sci. Rep., 2017, 7, 1729.
[25] Bluyssen H., Rastmanesh M., Tilburgs C., Jie K., Wesseling S., Goumans M., et al.: “IFN gamma-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells”. Am. J. Physiol. Cell. Physiol., 2010, 299, C354.
[26] Frederiksen L., Ernst A., Brix N., Braskhoj Lauridsen L., Roos L., Ramlau-Hansen C., et al.: “Risk of Adverse Pregnancy Outcomes at Advanced Maternal Age”. Obstet. Gynecol., 2018, 131, 457.
[27] Vesce F., Scapoli C., Giovannini G., Tralli L., Gotti G., Valerio A., et al.: “Cytokine imbalance in pregnancies with fetal chromosomal abnormalities.” Hum. Reprod., 2002, 17, 803.
[28] Lea R., Tulppala M., Critchley H.: “Deficient syncytiotrophoblast tumour necrosis factor-alpha characterizes failing first trimester pregnancies in a subgroup of recurrent miscarriage patients.” Hum. Reprod., 1997, 12, 1313.
[29] Patni S., Bryant A., Wynen L., Seager A., Morgan G., Thornton C.: “Functional activity but not gene expression of toll-like receptors is decreased in the preterm versus term human placenta”. Placenta, 2015, 36, 1031.
[30] Menon R., Richardson L., Lappas M.: “Fetal membrane architecture, aging and inflammation in pregnancy and parturition”. Placenta, 2018, pii, S0143-4004(18) 31060-9.
[31] Kim C., Jung E., Kim E., Kim C., Lee J., Hwang J., et al.: “Chronic Placental Inflammation as a Risk Factor of Severe Retinopathy of Prematurity”. J. Pathol. Translational Med., 2018, 52, 290.
[32] Chisholm K., Norton M., Penn A., Heerema-McKenney A.: “Classification of Preterm Birth With Placental Correlates”. Ped. Developmental Pathol., 2018, 21, 548.
[33] Zhao S., Gu Y., Dong Q., Fan R., Wang Y.: “Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia”. Placenta, 2008, 29, 1024.
[34] Dimitriadis E., Stoikos C., Tan Y., Salamonsen L.: “Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation”. Endocrinology, 2006, 147, 3809.
[35] Blumenstein M., Keelan J., Bowen-Shauver J., Mitchell M.: “Suppressors of cytokine signaling proteins in human preterm placental tissues”. J. Mol. Endocrinol., 2005, 35, 165.
[36] Simoni M., Mu L., Collins S.: “Women’s career priority is associated with attitudes towards family planning and ethical acceptance of reproductive technologies”. Hum. Reprod., 2017, 32, 2069.
[37] Agarwal A., Mulgund A., Hamada A., Chyatte M.: “A unique view on male infertility around the globe”. Reprod. Biol. Endocrinol., 2015, 13, 37.
[38] Messerlian C., Maclagan L., Basso O.: “Infertility and the risk of adverse pregnancy outcomes: a systematic review and meta-analysis”. Hum. Reprod., 2013, 28, 125.
[39] de Waal E., Vrooman L., Fischer E., Ord T., Mainigi M., Coutifaris C., et al.: “The cumulative effect of assisted reproduction procedures on placental development and epigenetic perturbations in a mouse model”. Hum. Mol. Genet., 2015, 24, 6975.
[40] Chen S., Sun F., Huang X., Wang X., Tang N., Zhu B., et al.: “Assisted reproduction causes placental maldevelopment and dysfunction linked to reduced fetal weight in mice”. Sci. Rep., 2015, 5, 10596.
[1] Pelin Kutlu, Seda Karabulut, Oya Korkmaz. Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1025-1031.
[2] Arzu Yurci, Nur Dokuzeylul Gungor, Tugba Gurbuz. Defective expression of endometrial BMP-2 contributes to subfertility in women with unexplained infertility[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1094-1098.
[3] Lorenz Hinterleitner, Herbert Kiss, Johannes Ott. The impact of Cesarean section on female fertility: a narrative review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 781-786.
[4] Sema Karakaş, Cihan Kaya, Sebastian Daniel Schäfer, Mislav Mikuš, Milan Terzic, Bekhzod Abdullaev, Alessandra Andrisani. Fertility-sparing in cancer patients[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 787-794.
[5] Sevcan Arzu Arinkan, Hilal Serifoglu. The possible association of uterine fibroid formation with copper intrauterine device use: a cross-sectional study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 969-973.
[6] Martin Klein, Lenka Lapides, Denisa Fecmanová, Ivan Varga. Novel cellular entities and their role in the etiopathogenesis of female idiopathic infertility—a review article[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 461-465.
[7] Banuhan Şahin, Buğra Şahin, Pervin Karlı, Görker Sel, Şafak Hatırnaz, Osman Fadıl Kara, Andrea Tinelli. Level of depression and hopelessness among women with infertility during the outbreak of COVID-19: a cross-sectional investigation[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 594-600.
[8] Engin Turkgeldi, Sule Yildiz, Berk Angun, Bulent Urman, Baris Ata. Oocyte yield of GnRH antagonist cycles scheduled with a short course of estradiol in the early follicular phase[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 278-282.
[9] Guy Shrem, Nouf M. Alasmari, Jacques Balayla, Alexander Volodarsky-Perel, Weon-Young Son, Michael H. Dahan. Paternal age predicts live birth in women above 40 years of age undergoing in-vitro fertilization (IVF)[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 299-306.
[10] R. Duraker, E.S. Guvendag Guven, S. Dilbaz, A. Mentese, S. Aydın, S. Guven. Oxidative stress status in severe OHSS patients who underwent long agonist protocol intracytoplasmic sperm injection cycles[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 312-316.
[11] Mahvash Zargar, Razieh Pazhouhanfar, Mahin Najafian, Parastoo Moradi Choghakabodi. Effects of intrauterine autologous platelet-rich plasma infusions on outcomes in women with repetitive in vitro fertilization failures: a prospective randomized study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 179-184.
[12] A. Yaylalı, M. Bakacak, Z. Bakacak, F. Tolun. An investigation of the effects on follicular-embryonal development and pregnancy outcomes of serum and follicular fluid ischemia-modified albumin in cases of unexplained infertility receiving in vitro fertilization treatment[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 835-839.
[13] I. Thanaboonyawat, P. Chera-aree, S. Petyim, R. Choavaratana, P. Laokirkkiat. The effect of three-month topical testosterone gel application on semen quality in men with oligozoospermia and low serum testosterone levels[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 875-881.
[14] K. Okuno, K. Kitaya, N. Kim, K. Yamaguchi, H. Matsubayashi, T. Ishikawa. Case report of successful live birth in an infertile couple with male idiopathic hypogonadotropic hypogonadism/azoospermia and atypical polypoid adenomyoma of the uterus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 972-973.
[15] S. Furukawa, L. Yang, H. Sameshima. Combination of lipopolysaccharide and hypoxia-ischemia attenuates cholinergic anti-inflammatory effect in newborn rat brains[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 736-740.
No Suggested Reading articles found!